90 took France trial drug that left 1 brain-dead,5 in hospital

January 16, 2016 02:09

One person has been left brain-dead and three others face possibly irreversible brain damage after they took an experimental drug administered to 90 people in France, Health Minister Marisol Touraine and a neurologist said today.

Six volunteers were taken to hospital last week after taking part in the Phase I trial of a new medication meant to treat mood disorders such as anxiety, developed by Portuguese pharmaceutical company Bial.

Touraine said the men, aged between 28 and 49, were part of a group of around 90 people who had taken the drug, while about 30 others had received a placebo.

The volunteers were given varying doses but the six men were in the group who were taking the drug "regularly". Pierre-Gilles Edan, head of the neurology department at the hospital in Rennes where the volunteers were taken, said that aside from the man who was clinically dead, three others were suffering a "handicap that could be irreversible" and another also had neurological problems.

Picture for representation only,

« Back to LIVE

TOP STORIES

Modi will make Amit Shah PM, finish Yogi politically: Kejriwal

A day after his release on interim bail, Delhi Chief Minister Arvind Kejriwal launched a blistering attack on Prime Minister Narendra Modi, alleging he was on a 'One nation, One leader' mission to impose 'dictatorship' by putting all...

Mbappe confirms departure from Paris Saint Germain

Coach Enrique understands Mbappe's decision to leave PSG

IPL 2024: 'Sudharsan needs to be spoken about more'

Gujarat Titan's Sai Sudharsan is the quickest Indian in terms of innings to reach 1,000 runs in IPL.

Rajasthan hopeful to beat the heat and CSK to cement top spot

'We just need to keep backing ourselves. With three games to go, we don't want to test ourselves but keep the momentum going.'

England's pace great Anderson to retire from Tests in July

James Anderson will retire from Test cricket after the first match of the series against West Indies at Lord's this year.